Results 251 to 260 of about 177,018 (304)

Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial. [PDF]

Blood Adv
Balke-Want H, Gödel P, Schmid C, Ayuk F, Friedrichs B, van Heteren P, Holtkamp S, Zadoyan G, Brillant C, Costa J, Hanssens L, Holzer T, Wöhle C, Biedermann S, Bürger I, Orentas R, Overstijns T, Scheid C, Holtick U, Miltenyi S, Hallek M, Borchmann P, Kutsch N.   +22 more
europepmc   +1 more source

Efficacy and safety analysis of CAR-T cell salvage therapy in relapsed/refractory diffuse large B-cell lymphoma after failure of bispecific antibody treatment. [PDF]

J Transl Med
Li F, Wang H, Liang Y, Liu X, Ye J, Yao N, Yang L, Wu Y, Wang L, Cong J.   +9 more
europepmc   +1 more source

Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis. [PDF]

CPT Pharmacometrics Syst Pharmacol
Nakada T, Saito R, Ishigaki S, Takei H, Yoshimoto K, Akiyama M, Takeuchi T, Kaneko Y, Miyoshi F.   +8 more
europepmc   +1 more source

Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders. [PDF]

MedComm (2020)
Fan Z, Zhang L, Yu H.
europepmc   +1 more source

A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells. [PDF]

Bio Protoc
Kubo N, Baba M, Suzuki Y, Kasahara Y, Hosokai R, Imamura M, Saitoh A, Imai C.   +7 more
europepmc   +1 more source

Donor-derived CD19-targeted CAR-NK cells induce complete remission in a child with relapsed B-ALL after failure of blinatumomab and autologous CD19-targeted CAR-T. [PDF]

J Immunother Cancer
Wang N, Liu L, Zhang L, Li J, Wan Y, Li X, Chen X, Yin Z, Zhang A, Zhang X, Chen Y, Hu T, Zhang Y, Liu F, Zhu X, Yang W.   +15 more
europepmc   +1 more source

Schnitzler Syndrome as an Autoinflammatory Disease Driven by B‐Cell‐Specific Somatic MYD88 Mutation

Allergy, EarlyView.
Yuyi Zhou, Yoko Ueki, Naoya Iwata, Hiroshi Oue, Kentaro Kato, Mengyan Li, Kazushi Izawa, Tomoyasu Jo, Seishi Ogawa, Kenji Kabashima, Naotomo Kambe   +10 more
wiley   +1 more source